SEP 14, 2020 2:46 PM PDT

MiR-107 and Its Role in Radiosensitivity in Prostate Cancer

WRITTEN BY: Jasper Cantrell

It is often unknown whether a patient will respond to a treatment until it is in full swing. New research is attempting to identify chemo and radiosensitivity mechanisms in cancers and how to use them to reverse resistances.

An area of keen interest is microRNAs and their role in cancer. MicroRNAs (miRNAs) are small snippets of RNA that regulate many processes in the cell. During the development of cancer, their levels fluctuate and can become inactive or overactive. This new study wanted to focus on one miRNA in particular, miR-107, and its effect on prostate cancer’s radiosensitivity.

Previous studies had already shown that miR-107 becomes downregulated after radiation therapy. A link between miR-107 and a pro-cancer growth factor called granulin had previously been identified, but not in the context of radiation therapy. The team hypothesized that both miR-107 and granulin might play a role in the radiosensitivity of prostate cancer.

They first confirmed that miR-107 was downregulated after radiotherapy by following its prostate cancer cell line levels before and after radiation. Artificially upregulating miR-107 impaired prostate cancer cells’ growth after radiation, inferring miR-107 has tumor suppressor activities.

Next, the team looked at granulin levels in the same settings. A previous study and several prediction tools showed the miR-107 should target and regulate granulin expression. Granulin was also upregulated in prostate cancer cells after radiation, in contrast to the downregulation in miR-107. When miR-107 was artificially upregulated, granulin levels went down in response, which effectively showed miR-107 likely regulated granulin in prostate cancer cells. The anti-cancer effects seen in miR-107 upregulation were also found to be due to its regulation of granulin, as knockdown of granulin caused the same results.

This study successfully revealed miR-107 as a player in the radio-sensitivity of prostate cancer cells through its regulation of granulin. Granulin has been linked to cancer progression in several previous studies and is upregulated after prostate cancer radiation. Artificial upregulation of miR-107 suppresses granulin levels and impairs cancer growth. One could imagine a miR-107 upregulating therapy alongside radiotherapy for maximum effectiveness.

The study concludes, “Collectively, these data suggest an unrecognized mechanism of miR-107/ GRN regulation in response to ionizing radiation, which provide a potential therapeutic strategy for improving radiosensitivity of prostate cancer.”

Sources: Nature Scientific Reports, Memorial Sloan Kettering

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
NOV 15, 2020
Genetics & Genomics
Novel Cancer-Driving Genes are Discovered
NOV 15, 2020
Novel Cancer-Driving Genes are Discovered
Cells have to be able to divide so new ones can replenish cells that get worn out, dysfunctional, or that accumulate dam ...
NOV 19, 2020
Cancer
New technique to synthesize phenazines offers hope for cancer treatments
NOV 19, 2020
New technique to synthesize phenazines offers hope for cancer treatments
Research from Tokyo University of Science investigators highlights new accomplishments in the fight against cancer. The ...
DEC 11, 2020
Cancer
Fan therapy proves to improve breathlessness in patients with advanced cancer
DEC 11, 2020
Fan therapy proves to improve breathlessness in patients with advanced cancer
New research released from Johns Hopkins Kimmel Cancer Center suggests that the air from fans may help patient ...
DEC 16, 2020
Cancer
More young adults are being diagnosed with esophageal adenocarcinoma
DEC 16, 2020
More young adults are being diagnosed with esophageal adenocarcinoma
New research published in a journal of the American Association for Cancer Research, Cancer Epidemiology, Biomarkers &am ...
DEC 31, 2020
Cancer
Does inflammation make ADT symptoms worse?
DEC 31, 2020
Does inflammation make ADT symptoms worse?
A new study published in the journal Cancer considers the impact of inflammation on prostate cancer patients underg ...
JAN 09, 2021
Cancer
Automated system provides guidance for cancer patients' symptoms
JAN 09, 2021
Automated system provides guidance for cancer patients' symptoms
A new computer system called eRAPID has been debuted in a UK trial to test out how it can assist cancer patients in mana ...
Loading Comments...